Presenter: Zonya Foco, RDN

Popular GLP-1 medications can provide short-term appetite suppression leading to weight loss, but do not correct the underlying drivers of appetite dysregulation—nor the associated nutrient deficiencies. Risks of long-term GLP-1 use include muscle loss, osteoporosis, and gastrointestinal disruption.

In this webinar Zonya Foco, RDN, will discuss the underlying nutritional imbalances, inflammation, and metabolic dysfunction that are contributing to the epidemic of obesity. She will highlight evidence-based ways to stimulate natural GLP-1 production, helping patients reduce cravings and realize sustainable, medication-free weight loss.

This webinar is designed for medical professionals and is part of the lead-up to the ISOM Polypharmacy Reduction Conference, on October 3 and 4, 2025.

Date: July 30, 2025

Start time: 8:00pm EDT / 5:00pm PDT